Exelixis clears flat base buy point, earns IBD Stock of the Day
Against the backdrop of a market that scores technical setups against earnings results, Exelixis (EXEL) offered a clear resolution. The stock cleared a flat-base buy point at 57.57 and is now trading at 59.08, carrying a 42%…
Key takeaways
- Investor's Business Daily named Exelixis (EXEL) its Stock of the Day after the stock cleared a flat-base buy point at 57.57.
- Exelixis is trading at 59.08 inside IBD's designated buy zone, which spans 57.57 to 60.45.
- The stock arrived at the breakout carrying a 42% advance, and the day's change was 0.05, or 0.08 percent.
- IBD assigns Exelixis a Composite Rating of 99 out of 99, its top reading.
- Exelixis' industry group ranks 27th out of 197 in IBD's classification, a front-quartile position.
Against the backdrop of a market that scores technical setups against earnings results, Exelixis (EXEL) offered a clear resolution. The stock cleared a flat-base buy point at 57.57 and is now trading at 59.08, carrying a 42% advance, after Investor's Business Daily named it Stock of the Day in a note that addressed both the earnings stumble and the price action that followed.
IBD does not look past the earnings snag. The Stock of the Day analysis names it plainly, then moves to the chart. The stock moved through the buy point regardless, and Exelixis is now inside the designated buy zone, which IBD places between 57.57 and 60.45. The day's change is 0.05, or 0.08 percent.
The pattern and what it signals
The flat base is one of three positive chart patterns IBD tracks in its technical methodology. Per IBD's description, the formation typically develops after a stock has already advanced meaningfully, building a period where prior gains are held before the next directional move. IBD classifies the flat base in Exelixis as an emerging pattern. The breakout signal comes when the stock clears the high of the base range, which was set at 57.57.
Exelixis arrived at that trigger carrying a 42% advance. A flat base absorbing a move of that size is a meaningful consolidation by the pattern's own logic. The stock cleared it. At 59.08, Exelixis is inside the buy zone, with the upper boundary at 60.45 marking the limit of the entry range.
Ratings and peer standing
IBD assigns Exelixis a Composite Rating of 99 out of 99, the top reading on a scale that blends the firm's fundamental and technical data. The stock's industry group ranks 27th out of 197 in IBD's classification, a front-quartile position among peer names.
The ratings and group rank put Exelixis near the top of what IBD's methodology is built to surface. The earnings result named in the same note is the open fundamental question. The breakout is the market's current answer to it. Whether that answer holds will show at 60.45, the level that closes the buy zone.
Related reading
Source · 來源